28 July 2020

European grant for developing innovative cancer drug

Scientists at Maastricht University Medical Center (MUMC+) and Maastro irradiation clinic have received a 150,000 euro grant from the European Research Council to help them bring an innovative cancer drug a step closer to being available to patients. The Maastricht researchers have their eyes on two promising substances that are able to shut down a specific development process in cancer stem cells. Among other things, this should increase the effect of other therapies and reduce the risk of metastasis.